Encore Medical Starts U.S. IPO Process

Encore Medical aims to raise $17.25M in IPO funding for FDA heart device trials. Click here to read the latest analysis on ...
MedPage Today on MSN

Stent Graft for Ruptured AAA; Biodegradable PFO Occluder; 24/7 Vascular Service Sued

The Medtronic Endurant stent graft system got FDA approval to remove a warning against use for ruptured abdominal aortic ...
abc27

NobleStitch™ Suture-Mediated PFO Closure Demonstrates Superior Long-Term Safety and Outcomes in Largest Cohort to Date

While other device-based closures have demonstrated notable rates of atrial fibrillation (5.7–6.6%) and device-related adverse events, the NobleStitch™ system's fully suture-mediated approach ...

Intracardiac echocardiography recognized as ‘transformative’ imaging modality in new SCAI position statement

The Society for Cardiovascular Angiography & Interventions (SCAI) has published a comprehensive roadmap that details the use of intracardiac echocardiography (ICE) to guide structural heart disease ...
Nature

Risk of Ischemic Stroke After Patent Foramen Ovale Closure

The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...